ACPE approves expansion of Pharm.D. program
In an effort to transform health care for patients through pharmacy practice, the Texas A&M Irma Lerma Rangel College of Pharmacy opened additional seats in its Doctor of Pharmacy (Pharm.D.) program this fall by expanding to College Station.
Following an onsite evaluation by an accreditation team during April 30-May 1, the expansion of the Pharm.D. program to the Bryan-College Station campus was approved by the Accreditation Council for Pharmacy Education (ACPE). The college received notification of the accreditation affirmation in July.
The main campus in Kingsville will welcome 87 students and the College Station campus will have 33 students.
“We are thrilled to have received affirmation of our program expansion to Aggieland,” said Indra K. Reddy, Ph.D., professor and founding dean of the Texas A&M Rangel College of Pharmacy. “The college has been working diligently on this expansion for a while and I owe a tremendous gratitude to our faculty, staff and administrative leadership who have worked together to make this happen. We are eagerly looking forward to welcoming a new cohort for the Class of 2018 on the campuses of Kingsville and College Station. Together, these groups will help lead the college through its next, exciting chapter as we move forward to advance pharmacy education and practice in our state and beyond.”
The Class of 2018 joins colleagues in one of the Top-50 ranked programs in the nation, according to U.S. News & World Report. Each professional student pharmacist will help to improve access, affordability and improved health care across the state.
Since graduating its inaugural class in 2010, the college has added 395 pharmacists to the workforce with 45 percent from South Texas and one-third practicing in the region. The Texas A&M Rangel College of Pharmacy was established in 2006 to meet the demand for pharmacists in the South Texas region.
ACPE is the national agency for the accreditation of professional degree programs in pharmacy education.